Colon Cancer Antibodies
Colon cancers are the 4th most diagnosed cancer in the United States, with about 8% of all new cancer cases classified as colon and rectal cancer, contributing approx. 8.4% of cancer deaths yearly. As of 2012, there were approximately 1,170,000 people living with colon and rectal cancers in the United States. Those diagnosed with colon cancer have a 5 year survival rate of 64.9%. Over the last 10 years, the new cancer case rate has fallen an average of 3.1% each year but the death rate has been stable. Biocare Medical is proud to offer key colon antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.
SEER Cancer Statistics Factsheets: Colon and Rectum Cancer. National Cancer Institute. Bethesda, MD,https://seer.cancer.gov/statfacts/html/colorect.html